Jordi Hays
Co-host of TBPN, where he discusses technology and business news with John Coogan.
Midjourney Medical Extends Image-Generation Ambitions Into Full-Body Ultrasound Scanning
TBPN hosts John Coogan and Jordi Hays read Midjourney Medical as a continuation of David Holz’s long-running work on sensing, interfaces and machine perception, rather than a sudden move from image generation into healthcare. Their account argues that Midjourney’s unusual business — bootstrapped, community-driven and cash-generative — has given Holz room to attempt a capital-intensive ultrasound scanning system with ambitions far beyond a conventional clinic device. The episode pairs that bet with OpenAI’s hiring of Noam Shazeer and Dean Ball as evidence that technical talent, policy capacity and institutional advantage are converging in AI.
Anti Fund Raises $100M to Back AI, Defense, and Robotics
Jake Paul and Anti Fund co-founder Geoffrey Woo argue that their venture firm is moving beyond celebrity access into institutional frontier investing, with an oversubscribed $100mn-plus growth fund and a focus on AI, defense, robotics, energy, hardware and other capital-intensive technologies. In a TBPN conversation, Paul frames his media career and boxing promotion business as evidence that he can help technical companies build distribution, while Woo says the firm’s thesis is shifting toward AI infrastructure and the physical world.
Snap’s Specs Face a Public-Market Test After Years of AR Spending
On Diet TBPN, John Coogan and Jordi Hays used Snap’s new Specs as the clearest case for a broader skepticism: technically strong demos do not answer whether a company can create demand, an ecosystem, or a rational return on capital. They argued that Snap’s AR work might look fundable as a startup but is harder to defend inside a public company whose stock has fallen sharply and whose core ads business could be run more profitably. The same standard shaped their read on Taste Labs, AI export-control fights, and SpaceX’s valuation: the hard question is whether impressive capability can be converted into durable business control.
SpaceX’s Cursor Deal Shows Platform Control Is Being Repriced
John Coogan and Jordi Hays argue that SpaceX’s reported $60bn all-stock acquisition of Cursor only looks small because SpaceX’s market value has surged into the trillion-dollar tier. Their broader case is that platform control is being repriced across tech: SpaceX can use an inflated equity currency to buy AI assets, Cursor’s value depends on unstable relationships with model and compute providers, and Snap’s expensive AR glasses face the same hard question as every would-be platform — whether users and developers will actually show up.
Export Controls Turn Frontier AI Access Into a Political Problem
John Coogan framed Anthropic’s Fable/Mythos suspension as both an export-control crisis and a sign that frontier AI companies are poorly aligned with Washington’s current political and security instincts. On Diet TBPN, Coogan and Jordi Hays argued that the same access problem is appearing across tech and media: foreign-national limits complicate AI development and sales, Meta’s AI use is being pulled back into budget discipline, and Fox’s reported Roku deal is a bet that control of connected-TV distribution will matter as ad-supported streaming grows.
SpaceX’s Public-Market Case Now Runs Through AI Compute
Gavin Baker, in a TBPN conversation following the SpaceX IPO, argues that the company’s public-market case is not mainly a long-dated bet on Mars. He says SpaceX could become one of the most important companies in history because it is positioned around nearer-term AI infrastructure scarcity: energized gigawatts, fast data-center deployment, high-value token production and, eventually, orbital compute enabled by reusable launch. Baker also frames retail capital, sovereign AI and semiconductor bottleneck trades through that same question of who controls durable capacity in the AI endgame.
SpaceX Opens Near $2.3 Trillion After Orderly IPO Pop
Jordi Hays and John Coogan read SpaceX’s public-market debut as a well-managed success, not because it produced a spectacular first-day surge, but because a roughly mid-20s pop at a multi-trillion-dollar valuation showed strong demand without disorder. On TBPN’s Diet episode, they argued that scarce allocations, Gwynne Shotwell’s operating role, and SpaceX’s two-decade execution record made the listing look credible even as they stopped short of settling the company’s valuation case.
Prometheus Raises $12 Billion as Industrial AI Moves to IPO Scale
On Diet TBPN, John Coogan and Jordi Hays treat Jeff Bezos’s Prometheus as the clearest sign that AI infrastructure and industrial ambition are being financed at public-company scale before the business model is visible. Coogan argues the $12 billion raise reflects the cost of trying to compress physical engineering cycles, while Hays presses the implication that only a founder such as Bezos could raise that much capital with so little public detail. The episode extends that capacity frame to freight and Texas, with Hays describing trucking’s rebound as a supply-driven rate recovery and Coogan presenting Texas as a corporate center of gravity built on energy, data centers, headquarters moves and market infrastructure.
Undisclosed Model Degradation Becomes the Flashpoint in Anthropic’s Safety Debate
Anthropic’s Fable 5 launch, Meta’s renewed Facebook film problem and SpaceX’s prospective IPO were judged on Diet TBPN less by their headlines than by the product and market mechanics underneath them. John Coogan’s sharpest concern was Anthropic, where he argued that visible guardrails and model degradation disclosed in a model card but not surfaced inside the product risk turning a capability launch into a trust problem for paying users and developers. On Meta and SpaceX, Coogan saw more limited business consequences than the public narratives suggest: The Social Reckoning may hurt Meta’s reputation without materially damaging its advertising business, while SpaceX’s small initial free float could make the IPO less disruptive than a $1.8tn valuation implies.
Apple’s New Siri Tests Who Controls the Default AI Assistant
John Coogan and Jordi Hays read Apple’s WWDC as a test of whether the company can turn its long-delayed Siri promise into a defensible AI interface without giving up control of defaults, privacy, and the iPhone camera. The Diet TBPN segment argues that Apple’s AI story is less about a single keynote than about older bets now becoming technically possible, while Anthropic’s Claude Fable release and Meta’s data-center training push show the same shift toward long-running inference and physical AI infrastructure.
Apple’s AI Challenge Shifts From Invention to iPhone Integration
John Coogan used Diet TBPN’s WWDC discussion to argue that Apple’s AI challenge is now less about inventing a breakthrough than deciding how deeply Siri, iOS, third-party models and cloud inference can touch the iPhone without breaking Apple’s privacy and product-control instincts. The episode also framed strong US hiring as a problem for tech’s rate-cut hopes, and separated viral VC pitch-room complaints from the more serious risk of opaque financing structures that founders may misrepresent.
Apple’s WWDC Leaves Siri-Scale AI Infrastructure Questions Unanswered
John Coogan and Jordi Hays used Apple’s WWDC announcements to argue that Apple’s AI challenge has shifted from invention to integration: putting familiar model behaviors inside Siri, iOS and Mac workflows without breaking the company’s privacy and product-control instincts. The discussion also treated Apple’s “private cloud” language as an unresolved infrastructure question, then turned to strong U.S. jobs data as a check on AI layoff claims and to viral VC horror stories as a distinction between bad fundraising theater and more serious disclosure or board-level problems.
Tech’s Hard Problems Are Moving From Demos to Deployment
TBPN’s Jordi Hays and John Coogan use Apple’s WWDC, the jobs report, venture-capital disputes, and interviews with operators in satellites, biotech, fusion, robotics and nuclear power to frame a recurring divide between demonstration and deployment. Their argument is that AI features, reactors, robots, medicines and market stories are now being judged less by whether they can be shown than by whether they can be operated at scale, with infrastructure, regulation, capital and user trust doing much of the hard work.
AI’s Enterprise Bottleneck Is Judgment, Not Model Access
Palantir chief executive Alex Karp argues that the scarce resource in enterprise AI is not model access but taste: the judgment to choose problems worth solving and attach AI to real operational processes. In a live AIPCon 10 conversation, Karp says companies are too often “tokenmaxxing” — generating AI activity that looks productive but does not change the business — while underestimating the political backlash that could lead to poorly designed regulation or even nationalization.
AI Leaders Urge Mandatory Checks on Synthetic Nucleic Acid Orders
TBPN’s John Coogan and Jordi Hays treated a new AI-biosecurity letter as the day’s most consequential signal: the risk is not near-term AGI designing pathogens from scratch, Hays argued, but an inadequately policed supply chain for synthetic nucleic acids. The letter, signed by AI and biotech figures including Demis Hassabis, Sam Altman and Dario Amodei, calls for mandatory screening and recordkeeping for DNA orders and related equipment, replacing a voluntary regime Hays said leaves meaningful gaps. The episode also read Ramp’s $44bn valuation, Sabi’s leaked BCI round and Benchmark’s first growth fund as signs of capital moving toward AI-adjacent infrastructure, finance and biology.
Enterprise AI’s Constraint Is Judgment, Not Token Consumption
At TBPN’s AIPCon 10 broadcast, Palantir chief executive Alex Karp argued that enterprise AI’s central problem is no longer model capability but organizational judgment: companies are consuming tokens, dashboards and AI-generated artifacts without tying them to decisions that change operations. AIG’s Peter Zaffino, Palantir’s Chad Wahlquist and USDA’s Sam Berry extended the same case from insurance, deployment architecture and government data systems, describing AI as valuable only when embedded in workflows, data structures and feedback loops that reflect how institutions actually work.
Microsoft Bets Enterprise Agents Will Run Through the Cloud
John Coogan reads Microsoft Build 2026 as a sign that Microsoft is trying to make the cloud, not the phone, the center of enterprise AI agents. On Diet TBPN, he argues that Project Solara, Scout, OpenClaw support and Microsoft’s own models point to a platform strategy built around Azure, Microsoft 365 data, security boundaries and cost-efficient deployment rather than frontier-model supremacy. The open question, he says, is whether agent hardware and workflows can win adoption outside environments where companies can mandate them.
Useful AI Systems Are Emerging Inside Controlled Enterprise Workflows
TBPN’s latest discussion framed the commercial AI moment less as a race to looser autonomy than as a shift toward bounded systems. Across Microsoft’s Build announcements, Suno’s funding, creator films, stablecoins, crypto markets, cybersecurity, and workflow software, the central argument was that AI becomes useful when it is embedded in infrastructure that can price, route, audit, secure, or constrain it. John Coogan and guests applied that lens most directly to Microsoft’s agent strategy, where Azure and Microsoft 365, not a new phone, become the controlled operating environment for enterprise agents.
Alphabet’s $80 Billion Raise Shows Public Markets Regaining AI Power
John Coogan used Diet TBPN’s discussion of Alphabet’s reported $80 billion equity raise to argue that AI has made access to public-market capital strategically important again. Coogan, with Jordi Hays, framed the same pressure across OpenAI’s gigawatt data-center plans, confidential IPO filings and other market moves: AI companies are no longer just competing on products and models, but on their ability to finance infrastructure, absorb risk and time their access to public investors.
Public-Market Capital Is Becoming an AI Infrastructure Advantage
TBPN’s John Coogan and Jordi Hays use Alphabet’s reported $80bn equity raise, Berkshire Hathaway’s investment and a run of founder interviews to argue that AI is pushing capital markets and operating infrastructure back to the center of technology strategy. Their case is that the advantage is moving to companies that can finance enormous compute buildouts, unify fragmented data, own service businesses where AI can be deployed, and build the physical systems — from data centers to space logistics — that make AI useful.
YouTube-Native Filmmakers Are Turning Viral Proof Into Box-Office Hits
John Coogan and Jordi Hays use the box-office success of YouTube-native filmmakers to argue that Hollywood is beginning to treat creators as a source of proven taste and new IP, not merely as marketing channels. Their broader read is that proof of demand is moving earlier across markets: viral film concepts can become theatrical bets, AI labs are preparing for public ownership, and even Bernie Sanders’s proposed public stake in AI companies assumes the sector’s equity will be enormously valuable. The hosts are skeptical, however, that attention or ownership alone solves the harder questions of execution, cash flow, or public benefit.
YouTube Is Becoming Hollywood’s Talent Market and IP Proving Ground
TBPN’s John Coogan and Jordi Hays argue that YouTube is moving from Hollywood competitor to Hollywood’s talent market, where creator-led films prove creative judgment, production ability and audience response before studio capital arrives. The episode extends that pattern to AI policy, software and prediction markets: established institutions are trying to absorb signals formed outside their usual channels, from internet-proven filmmakers and frontier AI labs to traders and startups testing demand before regulators, studios or public markets have settled their response.
Enterprise AI Enters Its ROI Era as Token Costs Surge
John Coogan and Jordi Hays use the latest Diet TBPN to separate spectacle from operating reality: Blue Origin’s New Glenn explosion is a serious but recoverable setback in a capital-heavy launch race, while enterprise AI has moved from adoption theater into a phase where executives are asking what token spend actually produces. Their larger argument is that capital, cadence, and measurable output now matter more than headline momentum, whether in rockets, AI budgets, trophy fossil auctions, or frothy AI-adjacent markets.
AI Compute Remains Supply Constrained as Infrastructure Stocks Pull Ahead
Altimeter founder Brad Gerstner argues that the AI boom remains constrained by compute supply rather than exhausted demand, and says that view explains the firm’s large bets on OpenAI, Anthropic, Nvidia, Snowflake and related infrastructure. In a live TBPN conversation, he ties the investment case to a broader political one: the US must keep building data centers and compute capacity to compete with China, while using initiatives such as Trump Accounts to give more Americans a direct ownership stake in the wealth AI may create.